Evidence map›Paper›PMID 31898867›Full record

ArticleFEBS open bio2020

NF-kB signaling in cardiomyocytes is inhibited by sevoflurane and promoted by propofol.

Keiko Oda-Kawashima, Anna S Sedukhina, Naoki Okamoto, Mariya Lytvyn, Kimino Minagawa, Teppei Iwata, Toshio Kumai, Eri Sato, Eiichi Inada, Ayako Yamaura and 4 more

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Keiko Oda-KawashimaDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Anna S SedukhinaDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Naoki OkamotoDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Mariya LytvynCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Kimino MinagawaDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Teppei IwataDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Toshio KumaiDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Eri SatoDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Eiichi InadaAnesthesiology Division, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Japan.
Ayako YamauraDepartment of Anesthesiology, St. Marianna University School of Medicine, Kawasaki, Japan.
Miki SakamotoDepartment of Anesthesiology, St. Marianna University School of Medicine, Kawasaki, Japan.
Marta Roche-MolinaCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Juan A BernalCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Ko SatoDepartment of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.ORCID https://orcid.org/0000-0001-9727-5948
St. Marianna University School of Medicine · JPSpanish National Centre for Cardiovascular Research · ESJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both inhalational and intravenous anesthetics affect myocardial remodeling, but the precise effect of each anesthetic on molecular signaling in myocardial remodeling is unknown. Here, we performed in silico analysis to investigate signaling alterations in cardiomyocytes induced by inhalational [sevoflurane (Sevo)] and intravenous [propofol (Prop)] anesthetics. Bioinformatics analysis revealed that nuclear factor-kappa B (NF-kB) signaling was inhibited by Sevo and promoted by Prop. Moreover, nuclear accumulation of p65 and transcription of NF-kB-regulated genes were suppressed in Sevo-administered mice, suggesting that Sevo inhibits the NF-kB signaling pathway. Our data demonstrate that NF-kB signaling is inhibited by Sevo and promoted by Prop. As NF-kB signaling plays an important role in myocardial remodeling, our results suggest that anesthetics may affect myocardial remodeling through NF-kB.

Indexed as

AgedAnesthetics, IntravenousAnimalsAtrial RemodelingHeartHumansMaleMiceMiddle AgedMyocardiumMyocytes, CardiacNF-kappa BPropofolSevofluraneSignal TransductionVentricular RemodelingAnesthetics, IntravenousNF-kappa BPropofolSevofluraneanesthesiabioinformaticsmyocardial remodelingNF-kBpropofolsevoflurane

Identifiers

PMID31898867
PMCPMC6996339
OpenAlexW2997075338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.